Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer

Publisher： Karger

E-ISSN： 1661-3805|12|3|138-144

ISSN： 1661-3791

Source： Breast Care, Vol.12, Iss.3, 2017-06, pp. : 138-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identifying Biomarkers to Select Patients with Early Breast Cancer Suitable for Extended Adjuvant Endocrine Therapy

By  

Breast Care, Vol. 12, Iss. 3, 2017-06 ,pp. : 146-151

Karger

Access to resources Recommend Favorite

Adjuvant Antibody Therapy with Trastuzumab in Early Breast Cancer

By  

Breast Care, Vol. 1, Iss. 4, 2006-09 ,pp. : 252-255

Karger

Access to resources Recommend Favorite

Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy

By  

Breast Care, Vol. 11, Iss. 4, 2016-06 ,pp. : 240-246

Karger

Access to resources Recommend Favorite

Advances in Adjuvant and Primary Systemic Therapy of Early Breast Cancer

By  

Breast Care, Vol. 1, Iss. 2, 2006-05 ,pp. : 129-133

Karger

Access to resources Recommend Favorite

Chemoendocrine Treatment Is Standard in Hormone Receptor-Positive Patients

By  

Breast Care, Vol. 3, Iss. 4, 2008-08 ,pp. : 229-230

Karger

Access to resources Recommend Favorite